DK0813545T3 - Nukleotid- og proteinsekvenser af hvirveldyrs-Serrate-gener og fremgangsmåde baseret derpå - Google Patents

Nukleotid- og proteinsekvenser af hvirveldyrs-Serrate-gener og fremgangsmåde baseret derpå

Info

Publication number: DK0813545T3
Authority: DK; Denmark
Prior art keywords: serrate; analogs; derivatives; protein; genes
Prior art date: 1995-03-07

Application number

DK96911262T

Other languages

Danish (da)

English (en)

Inventor

Anna M Chawley Lane Myat

Grace E Apartment Gray

Spyridon Artavanis-Tsakonas

David Ish-Horowicz

Domingos M P Henrique

Julian H Lewis

Robert S Mann

Original Assignee

Univ Yale

Imp Cancer Res Tech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-07

Filing date

1996-03-07

Publication date

2009-12-14

1996-03-07 Application filed by Univ Yale, Imp Cancer Res Tech filed Critical Univ Yale

2009-12-14 Application granted granted Critical

2009-12-14 Publication of DK0813545T3 publication Critical patent/DK0813545T3/da

Links

108010036039 Serrate-Jagged Proteins Proteins 0.000 title abstract 9
238000000034 method Methods 0.000 title abstract 2
108090000623 proteins and genes Chemical group 0.000 title abstract 2
102000004169 proteins and genes Human genes 0.000 title abstract 2
241000251539 Vertebrata <Metazoa> Species 0.000 title 1
239000002773 nucleotide Substances 0.000 title 1
125000003729 nucleotide group Chemical group 0.000 title 1
102000011842 Serrate-Jagged Proteins Human genes 0.000 abstract 6
239000012634 fragment Substances 0.000 abstract 2
241000255581 Drosophila <fruit fly, genus> Species 0.000 abstract 1
101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 abstract 1
241000282414 Homo sapiens Species 0.000 abstract 1
102000003839 Human Proteins Human genes 0.000 abstract 1
108090000144 Human Proteins Proteins 0.000 abstract 1
241000699666 Mus <mouse, genus> Species 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
241000269370 Xenopus <genus> Species 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
235000018417 cysteine Nutrition 0.000 abstract 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
238000002405 diagnostic procedure Methods 0.000 abstract 1
230000003834 intracellular effect Effects 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
235000018102 proteins Nutrition 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
- C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Insects & Arthropods (AREA)
Tropical Medicine & Parasitology (AREA)
Addiction (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Immunology (AREA)
Psychology (AREA)
Oncology (AREA)
Hematology (AREA)
Cell Biology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)

DK96911262T 1995-03-07 1996-03-07 Nukleotid- og proteinsekvenser af hvirveldyrs-Serrate-gener og fremgangsmåde baseret derpå DK0813545T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/400,159 US5869282A (en)	1991-12-11	1995-03-07	Nucleotide and protein sequences of the serrate gene and methods based thereon
PCT/US1996/003172 WO1996027610A1 (en)	1995-03-07	1996-03-07	Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon

Publications (1)

Publication Number	Publication Date
DK0813545T3 true DK0813545T3 (da)	2009-12-14

Family

ID=23582455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96911262T DK0813545T3 (da)	1995-03-07	1996-03-07	Nukleotid- og proteinsekvenser af hvirveldyrs-Serrate-gener og fremgangsmåde baseret derpå

Country Status (11)

Country	Link
US (1)	US5869282A (2)
EP (1)	EP0813545B1 (2)
JP (4)	JPH11507203A (2)
AT (1)	ATE442381T1 (2)
AU (1)	AU718955B2 (2)
CA (1)	CA2214830C (2)
DE (1)	DE69638022D1 (2)
DK (1)	DK0813545T3 (2)
ES (1)	ES2333384T3 (2)
PT (1)	PT813545E (2)
WO (1)	WO1996027610A1 (2)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6004924A (en)	1991-12-11	1999-12-21	Imperial Cancer Research Technology, Ltd.	Protein sequences of serrate gene products
US5869282A (en) *	1991-12-11	1999-02-09	Imperial Cancer Research Technology, Ltd.	Nucleotide and protein sequences of the serrate gene and methods based thereon
US20050112121A1 (en) *	1992-04-30	2005-05-26	Yale University	Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
EP0861261B9 (en) *	1995-06-28	2010-02-24	Imperial Cancer Research Technology Limited	Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
US20050158859A1 (en) *	1995-09-29	2005-07-21	Yale University	Manipulation of non-terminally differentiated cells using the Notch pathway
US5780300A (en) *	1995-09-29	1998-07-14	Yale University	Manipulation of non-terminally differentiated cells using the notch pathway
DE69635899T2 (de) *	1995-11-17	2006-11-23	Asahi Kasei Kabushiki Kaisha	Polypeptid, das die differenzierung unterdrueckt
DE69736109T2 (de) *	1996-07-16	2007-01-04	Asahi Kasei Kabushiki Kaisha	Differenzierungsinhibitor
AU773479B2 (en) *	1996-11-07	2004-05-27	Lorantis Limited	Notch
CZ295997B6 (cs) *	1996-11-07	2005-12-14	Lorantis Limited	Farmaceutický prostředek s obsahem ligandu Notch a způsob tvorby T-buněk
GB9623236D0 (en) *	1996-11-07	1997-01-08	Imperial College	Notch
US6887475B1 (en)	1996-11-07	2005-05-03	Lorantis Limited	Notch
JP4171528B2 (ja)	1997-05-14	2008-10-22	旭化成株式会社	新規な分化抑制剤
US6136952A (en)	1997-06-25	2000-10-24	University Of Washington	Human jagged polypeptide, encoding nucleic acids and methods of use
US6692919B1 (en)	1997-07-23	2004-02-17	Yale University	Activated forms of notch and methods based thereon
US6436650B1 (en)	1997-07-23	2002-08-20	Yale University	Activated forms of notch and methods based thereon
AU1054900A (en) *	1998-10-30	2000-05-22	Smith & Nephew Plc	Compositions comprising notch receptor manipulating agents
US8084258B2 (en) *	1999-07-12	2011-12-27	University Of Basel	Manipulation of tissue of organ type using the notch pathway
GB9927328D0 (en)	1999-11-18	2000-01-12	Lorantis Ltd	Immunotherapy
US8044259B2 (en)	2000-08-03	2011-10-25	The Regents Of The University Of Michigan	Determining the capability of a test compound to affect solid tumor stem cells
US6984522B2 (en) *	2000-08-03	2006-01-10	Regents Of The University Of Michigan	Isolation and use of solid tumor stem cells
AU2001288628A1 (en) *	2000-08-31	2002-03-13	Loyola University Chicago	Method and reagents for treatment of skin disorders by modulating the notch pathway
ATE398175T1 (de) *	2000-12-08	2008-07-15	Coley Pharmaceuticals Gmbh	Cpg-artige nukleinsäuren und verfahren zu ihrer verwendung
GB0118155D0 (en)	2001-07-25	2001-09-19	Lorantis Ltd	Superantigen
WO2003011317A1 (en) *	2001-07-25	2003-02-13	Lorantis Limited	Modulators of notch signalling for use in immunotherapy
CA2469204A1 (en) *	2001-12-07	2003-06-19	Regents Of The University Of Michigan	Prospective identification and characterization of breast cancer stem cells
US20030185829A1 (en) *	2002-03-12	2003-10-02	Erich Koller	Jagged 2 inhibitors for inducing apoptosis
US20040102401A1 (en) *	2002-11-22	2004-05-27	Isis Pharmaceuticals Inc.	Modulation of jagged 1 expression
GB0300428D0 (en) *	2003-01-09	2003-02-05	Lorantis Ltd	Medical treatment
GB0307472D0 (en) *	2003-04-01	2003-05-07	Lorantis Ltd	Medical treatment
EP1639090A4 (en) *	2003-06-09	2008-04-16	Univ Michigan	COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
AU2005209909B8 (en) *	2004-02-03	2009-01-15	The Regents Of The University Of Michigan	Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
US20060252073A1 (en) *	2005-04-18	2006-11-09	Regents Of The University Of Michigan	Compositions and methods for the treatment of cancer
WO2006135886A2 (en) *	2005-06-13	2006-12-21	The Regents Of The University Of Michigan	Compositions and methods for treating and diagnosing cancer
EP1907858A4 (en) *	2005-06-13	2009-04-08	Univ Michigan	COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
JP5129149B2 (ja)	2005-10-31	2013-01-23	ザリージェンツオブザユニバーシティオブミシガン	癌を処置および診断するための組成物および方法
DK2500360T3 (en)	2005-10-31	2015-10-26	Oncomed Pharm Inc	Compositions and methods for the diagnosis and treatment of cancer
US7723477B2 (en)	2005-10-31	2010-05-25	Oncomed Pharmaceuticals, Inc.	Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
WO2008121102A2 (en) *	2006-02-21	2008-10-09	The Regents Of The University Of Michigan	Hedgehog signaling pathway antagonist cancer treatment
WO2008092002A2 (en)	2007-01-24	2008-07-31	The Regents Of The University Of Michigan	Compositions and methods for treating and diagnosing pancreatic cancer
EP2155249A4 (en) *	2007-05-15	2011-11-16	Oncomed Pharm Inc	COMPOSITIONS AND METHOD FOR DIAGNOSIS AND TREATMENT OF CANCER
CN103002911B (zh)	2008-09-26	2015-08-26	昂考梅德药品有限公司	卷曲蛋白结合药剂及其应用
WO2011063237A2 (en)	2009-11-19	2011-05-26	Oncomed Pharmaceuticals, Inc.	Jagged-binding agents and uses thereof
TWI535445B (zh)	2010-01-12	2016-06-01	安可美德藥物股份有限公司	Ｗｎｔ拮抗劑及治療和篩選方法
CA2794674A1 (en)	2010-04-01	2011-10-06	Oncomed Pharmaceuticals, Inc.	Frizzled-binding agents and uses thereof
US20130095079A1 (en)	2010-04-09	2013-04-18	Fred Hutchinson Cancer Research Center	Compositions and methods for providing hematopoietic function without hla matching
US20130095080A1 (en)	2010-04-09	2013-04-18	Fred Hutchinson Cancer Reserach Center	Compositions and methods for providing hematopoietic function
CA2858069C (en)	2011-12-08	2020-02-11	Novartis Ag	Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
MX2014016038A (es)	2012-06-22	2015-08-14	Cytomx Therapeutics Inc	Anticuerpos de reaccion cruzada anti - jagged 1 / jagged 2, anticuerpos anti - jagged activables y metodos para uso de los mismos.
WO2014066328A1 (en)	2012-10-23	2014-05-01	Oncomed Pharmaceuticals, Inc.	Methods of treating neuroendocrine tumors using wnt pathway-binding agents
EP2943566A1 (en)	2013-01-08	2015-11-18	Fred Hutchinson Cancer Research Center	Compositions and methods for expansion of embryonic hematopoietic stem cells
JP2016510411A (ja)	2013-02-04	2016-04-07	オンコメッドファーマシューティカルズインコーポレイテッド	Ｗｎｔ経路インヒビターによる処置の方法およびモニタリング
US9168300B2 (en)	2013-03-14	2015-10-27	Oncomed Pharmaceuticals, Inc.	MET-binding agents and uses thereof
MX389160B (es)	2013-10-31	2025-03-20	Hutchinson Fred Cancer Res	Células no t efectoras y madre/progenitoras hematopoyéticas modificadas y usos de estas.
US10350245B2 (en)	2015-01-21	2019-07-16	Fred Hutchinson Cancer Research Center	Point-of-care and/or portable platform for gene therapy
WO2016176651A2 (en)	2015-04-29	2016-11-03	Fred Hutchinson Cancer Research Center	Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
EP3288570A4 (en)	2015-04-29	2018-11-21	Fred Hutchinson Cancer Research Center	Modified stem cells and uses thereof
MX2018006828A (es)	2015-12-04	2018-08-09	Hutchinson Fred Cancer Res	Usos de poblaciones expandidas de celulas madre/progenitoras hematopoyeticas.
US11617745B2 (en)	2018-08-17	2023-04-04	Frequency Therapeutics, Inc.	Compositions and methods for generating hair cells by downregulating FOXO
CN113195707A (zh) *	2018-08-17	2021-07-30	频率治疗公司	用于通过上调jag-1来生成毛细胞的组合物和方法
CN112680471B (zh) *	2019-10-17	2023-08-01	华南农业大学	ZmSPL基因在调控玉米柱头乳突细胞发育中的应用
EP4671372A3 (en)	2024-01-29	2026-03-11	Arnatar Therapeutics, Inc	Translation enhancing nucleic acid compounds: aso coupled translation - upregulation 1 (act-up1) and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4889818A (en)	1986-08-22	1989-12-26	Cetus Corporation	Purified thermostable enzyme
US4946778A (en)	1987-09-21	1990-08-07	Genex Corporation	Single polypeptide chain binding molecules
US5116742A (en)	1986-12-03	1992-05-26	University Patents, Inc.	RNA ribozyme restriction endoribonucleases and methods
US4795699A (en)	1987-01-14	1989-01-03	President And Fellows Of Harvard College	T7 DNA polymerase
US4981784A (en) *	1987-12-02	1991-01-01	The Salk Institute For Biological Studies	Retinoic acid receptor method
IL101728A (en) *	1991-05-03	2007-08-19	Univ Yale	Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
US5869282A (en) *	1991-12-11	1999-02-09	Imperial Cancer Research Technology, Ltd.	Nucleotide and protein sequences of the serrate gene and methods based thereon
WO1993012141A1 (en) *	1991-12-11	1993-06-24	Yale University	Nucleotide and protein sequences of the serrate gene and methods based thereon
US5786158A (en) *	1992-04-30	1998-07-28	Yale University	Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
DE69635899T2 (de) *	1995-11-17	2006-11-23	Asahi Kasei Kabushiki Kaisha	Polypeptid, das die differenzierung unterdrueckt
AU720890B2 (en) *	1996-05-31	2000-06-15	National American Red Cross, The	Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
AU8003400A (en) *	1999-10-06	2001-05-10	Ansgar H. Santel	Mitofusins, fzo homologs and functional derivatives thereof
JP5890756B2 (ja)	2012-06-28	2016-03-22	昭和電工株式会社	磁気記録媒体及び磁気記憶装置

1995
- 1995-03-07 US US08/400,159 patent/US5869282A/en not_active Expired - Lifetime
1996
- 1996-03-07 EP EP96911262A patent/EP0813545B1/en not_active Expired - Lifetime
- 1996-03-07 CA CA2214830A patent/CA2214830C/en not_active Expired - Lifetime
- 1996-03-07 WO PCT/US1996/003172 patent/WO1996027610A1/en not_active Ceased
- 1996-03-07 DE DE69638022T patent/DE69638022D1/de not_active Expired - Lifetime
- 1996-03-07 AU AU54202/96A patent/AU718955B2/en not_active Expired
- 1996-03-07 ES ES96911262T patent/ES2333384T3/es not_active Expired - Lifetime
- 1996-03-07 DK DK96911262T patent/DK0813545T3/da active
- 1996-03-07 JP JP8527061A patent/JPH11507203A/ja not_active Withdrawn
- 1996-03-07 PT PT96911262T patent/PT813545E/pt unknown
- 1996-03-07 AT AT96911262T patent/ATE442381T1/de active
2007
- 2007-10-03 JP JP2007260391A patent/JP2008099687A/ja not_active Withdrawn
2010
- 2010-07-23 JP JP2010166570A patent/JP2010273685A/ja not_active Withdrawn
2013
- 2013-02-08 JP JP2013023179A patent/JP2013150605A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CA2214830C (en)	2012-06-12
PT813545E (pt)	2009-12-16
JPH11507203A (ja)	1999-06-29
EP0813545A1 (en)	1997-12-29
JP2008099687A (ja)	2008-05-01
JP2013150605A (ja)	2013-08-08
AU5420296A (en)	1996-09-23
DE69638022D1 (de)	2009-10-22
CA2214830A1 (en)	1996-09-12
JP2010273685A (ja)	2010-12-09
AU718955B2 (en)	2000-05-04
WO1996027610A1 (en)	1996-09-12
EP0813545B1 (en)	2009-09-09
ATE442381T1 (de)	2009-09-15
US5869282A (en)	1999-02-09
EP0813545A4 (en)	2002-04-24
ES2333384T3 (es)	2010-02-19

Publication	Publication Date	Title
DK0813545T3 (da)	2009-12-14	Nukleotid- og proteinsekvenser af hvirveldyrs-Serrate-gener og fremgangsmåde baseret derpå
DK0861261T3 (da)	2009-12-14	Nukleotid- og proteinsekvenser af hvirveldyrs-Delta-gener og fremgangsmåder baseret derpå
UA103154C2 (uk)	2013-09-25	Hla-a*1101-обмежений пептид wt1 і фармацевтична композиція, яка містить його
DK0481000T3 (da)	1999-11-15	Receptorer for fibroblastvækstfaktorer
US8338136B2 (en)	2012-12-25	Method of producing a paralytic peptide
EA200300381A1 (ru)	2003-10-30	Нуклеиновые кислоты и полипептиды нового рецептора
PT93910A (pt)	1991-01-08	Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
EP1124846A4 (en)	2002-06-12	NOGO GENE NUCLEOTIDE AND PROTEIN SEQUENCES AND METHODS BASED ON SUCH SEQUENCES
NL300013I2 (nl)	2001-04-02	Nieuwe proteinen me TNF-remmende werking en hun bereiding.
DE602004001727D1 (de)	2006-09-14	Verfahren zur herstellung cyclischer peptide
DE60331546D1 (de)	2010-04-15	Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
JPH05508550A (ja)	1993-12-02	繊維芽細胞生育因子受容体
BR9508467A (pt)	1997-12-23	Composição de matéria peptídeo de ligação de receptor de somatostatina composição farmacéutica e processo para realizar uma cirurgia guiada por radiosótopos ou um procedimento de radiodiagnóstico ou radioterapéutico e para aliviar uma doença relacionada com somatostetina em um animal
ATE299029T1 (de)	2005-07-15	Verfahren und zusammensetzungen zur peptidsynthese (t-20)
CA2126212A1 (en)	1993-07-08	A novel molecule which inhibits neuropeptide tyrosine biological function
ATE321856T1 (de)	2006-04-15	Humane rezeptortyrosinkinase
PT996726E (pt)	2004-04-30	Proteina de membrana de celulas t (tirc7) peptidos e anticorpos dela derivados e suas utilizacoes
Hayashi et al.	2004	Long-sarafotoxins: characterization of a new family of endothelin-like peptides
DE69428292T2 (de)	2002-06-27	Rekombinanter c140-rezeptor, seine agonisten und antagonisten
EP1660659A2 (en)	2006-05-31	Gdnf-related neuropeptides
WO1997011091A1 (fr)	1997-03-27	Nouveaux composes peptidiques et leurs compositions medicinales
George et al.	1998	The phosphophoryn gene family: identical domain structures at the carboxyl end
WO1999063094A3 (en)	2000-04-13	Nucleotide and protein sequences of gpr1 and methods based thereon
NO20060675L (no)	2006-04-06	Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
AU5778600A (en)	2001-01-30	Compositions corresponding to a calcium transporter and methods of making and using same